Fishel Robert Scott 4
4 · Opko Health, Inc. · Filed Apr 17, 2018
Insider Transaction Report
Form 4
Fishel Robert Scott
Director
Transactions
- Purchase
Common Stock
2018-04-16$3.00/sh+5,000$15,000→ 4,026,428 total(indirect: See Footnote) - Purchase
Common Stock
2018-04-16$3.01/sh+10,000$30,100→ 4,036,428 total(indirect: See Footnote)
Footnotes (1)
- [F1]These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.